Osteoporosis Drugs Market Overview 2024: Size, Growth Drivers, and Major Segments
Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!
What is the Expected Growth Rate of the Osteoporosis Drugs Market for the Period 2024 to 2033?
In recent times, the osteoporosis drugs market has seen consistent expansion. It is projected to rise from a worth of $12 billion in 2023 to $12.48 billion in 2024, boasting a compound annual growth rate (CAGR) of 4.0%. This growth during the historical period is due to factors like the aging population, heightened diagnosis and awareness, lifestyle variables, government efforts, and health policy implementations.
In the coming years, the market size of osteoporosis drugs is predicted to experience consistent growth, ultimately reaching $14.2 billion in 2028 at a compound annual growth rate (CAGR) of 3.3%. This growth during the predicted period can be credited to enduring trends in the aging population, advancements in therapy choices, increased attention towards the bone health in men, initiatives towards patient information and self-sufficiency, worldwide health policies, and insurance provisions. The anticipated period will also witness trends like the application of personalized medicine, research into combined therapies, efforts towards fracture prevention, investments in the research and development of innovative drug targets, as well as partnerships for drug development.
Claim Your Free Sample of the Global Osteoporosis Drugs Market Report Today!
https://www.thebusinessresearchcompany.com/sample.aspx?id=9102&type=smp
What Factors Are Responsible for the Growth of the osteoporosis drugs Market?
The anticipated spike in incidences of osteoporosis is poised to stimulate the osteoporosis drug market’s expansion. Osteoporosis manifests as a decline in the bone mineral density and mass bone, or changes in bone quality. Individuals whose diet lacks adequate calcium stand a higher likelihood of contracting osteoporosis. Drugs for osteoporosis bolster bone mineral density while curtailing the occurrence of fractures. Case in point, statistics by Amgen a biotechnology enterprise based in the U.S, indicate that approximately 1.5 million fracture cases in the U.S each year are attributable to osteoporosis, spurring an expenditure of $19 billion in relevant costs. Furthermore, the figure for fractures resulting from osteoporosis is projected to swell by 68% from 1.9 million in 2018 to 3.2 million in 2040. As such, this burgeoning occurrence of osteoporosis is a key driver for growth in the osteoporosis drug market.
Which Segments Are Important for Insight into the Osteoporosis Drugs Market?
1) By Type: Bisphosphonates, Selective Estrogen Receptor Modulators (SERMs), RANK Ligand Inhibitors
2) By Administration: Oral, Injectable
3) By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Online Sales
4) By Application: Primary Osteoporosis, Secondary Osteoporosis
What Are the Significant Trends Reshaping the Osteoporosis Drugs Sector?
Order Now for Fast Delivery of Your Osteoporosis Drugs Market Report!
https://www.thebusinessresearchcompany.com/report/osteoporosis-drugs-global-market-report
Which Regions Are Essential for the Growth of the Osteoporosis Drugs Market?
North America was the largest region in the osteoporosis market in 2023. The regions covered in the osteoporosis drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The Osteoporosis Drugs Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the osteoporosis drugs market, its market share, and analyzes key competitors along with their market positions.
The Table Of Content For The Osteoporosis Drugs Market Include
1. Osteoporosis Drugs Market Executive Summary
2. Osteoporosis Drugs Market Segments
3. Osteoporosis Drugs Market Size And Template Market Growth Rate
4. Key Osteoporosis Drugs Market Trends
5. Major Osteoporosis Drugs Market Drivers
……
25. Key Mergers And Acquisitions In The Osteoporosis Drugs Market
26. Top Osteoporosis Drugs Companies
27. Osteoporosis Drugs Market Opportunities And Strategies
28. Osteoporosis Drugs Market, Conclusions And Recommendations
29. Appendix
Discover Related Reports by The Business Research Company:
Cardiovascular Surgery Devices And Equipment Global Market Report 2024
Cardiovascular Devices Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/cardiovascular-devices-global-market-report
Spinal Surgery Devices And Equipment Global Market Report 2024
Learn More About The Business Research Company
The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
